文献速递糖尿病

美国各州糖尿病归因经济成本估算

Economic Costs Attributable to Diabetes in Each U.S. State.
PubMed 文献 · Diabetes Care · 2018-10-10

该研究采用归因比例法估算直接医疗成本,采用人力资本法估算间接成本,基于2013年州健康支出账户等数据,将成本调整为2017年美元。

要点

  • 各州糖尿病归因经济成本中位数总计59亿美元,人均18,248美元。
  • 间接成本中位数30亿美元,人均9,672美元;患病间接成本通常大于死亡间接成本。

核心结论

  • 糖尿病归因经济成本很大且各州差异很大,各州特异性估算可为政策制定者提供必要信息。

研究设计与样本

  • 采用归因比例法估算直接医疗成本,数据来自2013年州健康支出账户、2013年行为风险因素监测系统和2013-2014年CMS最小数据集。
  • 采用人力资本法估算间接成本,包括患病(缺勤、假性出勤、家务生产力损失、无法工作)和过早死亡导致的生产力损失,数据来自2008-2013年全国健康访谈调查等,成本调整为2017年美元。

主要发现

  • 间接成本中位数30亿美元(范围0.4-32.6),人均9,672美元(范围7,133-17,962)。
  • 总体上,各州中位数间接成本中患病导致的成本在总计和人均上均大于死亡导致的成本。

临床怎么用

  • 各州政策制定者可利用州特异性估算监测糖尿病经济负担,并规划和评估2型糖尿病预防与管理干预措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate direct medical and indirect costs attributable to diabetes in each U.S. state in total and per person with diabetes. RESEARCH DESIGN AND METHODS: We used an attributable fraction approach to estimate direct medical costs using data from the 2013 State Health Expenditure Accounts, 2013 Behavioral Risk Factor Surveillance System, and the Centers for Medicare & Medicaid Services' 2013-2014 Minimum Data Set. We used a human capital approach to estimate indirect costs measured by lost productivity from morbidity (absenteeism, presenteeism, lost household productivity, and inability to work) and premature mortality, using the 2008-2013 National Health Interview Survey, 2013 daily housework value data, 2013 mortality data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research, and mean wages from the 2014 Bureau of Labor Statistics. Costs were adjusted to 2017 U.S. dollars. RESULTS: The estimated median state economic cost was $5.9 billion, ranging from $694 million to $55.5 billion, in total and $18,248, ranging from $15,418 to $30,915, per person with diabetes. The corresponding estimates for direct medical costs were $2.8 billion (range $0.3-22.9) and $8,544 (range $6,591-12,953) and for indirect costs were $3.0 billion (range $0.4-32.6) and $9,672 (range $7,133-17,962). In general, the estimated state median indirect costs resulting from morbidity were larger than costs from mortality both in total and per person with diabetes. CONCLUSIONS: Economic costs attributable to diabetes were large and varied widely across states. Our comprehensive state-specific estimates provide essential information needed by state policymakers to monitor the economic burden of the disease and to better plan and evaluate interventions for preventing type 2 diabetes and managing diabetes in their states.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Shrestha SS, Honeycutt AA, Yang W, et al. Economic Costs Attributable to Diabetes in Each U.S. State. Diabetes Care. 2018. PMID: 30305349. doi:10.2337/dc18-1179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。